HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guo-Hua Bi Selected Research

N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamide

10/2021Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Guo-Hua Bi Research Topics

Disease

9Opioid-Related Disorders (Opiate Addiction)
01/2022 - 10/2016
6Cocaine-Related Disorders (Cocaine Addiction)
10/2020 - 10/2012
3Substance-Related Disorders (Drug Abuse)
12/2018 - 10/2012
2Catalepsy
10/2021 - 01/2020
2Tobacco Use Disorder (Nicotine Dependence)
12/2019 - 01/2017
2Pain (Aches)
11/2019 - 10/2016
1Motor Disorders
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Hypothermia
01/2020
1Epilepsy (Aura)
01/2020
1Hyperalgesia
12/2019
1Obesity
03/2019
1Heroin Dependence (Heroin Abuse)
12/2018
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
12/2018
1Sleep Wake Disorders
06/2015
1Mental Disorders (Mental Disorder)
03/2015

Drug/Important Bio-Agent (IBA)

7Opioid Analgesics (Opioids)IBA
10/2021 - 10/2016
4Pharmaceutical PreparationsIBA
01/2022 - 10/2016
4Dopamine D3 ReceptorsIBA
01/2019 - 02/2014
3CB2 Cannabinoid ReceptorIBA
01/2021 - 01/2020
3CannabinoidsIBA
01/2021 - 01/2020
3Dopamine (Intropin)FDA LinkGeneric
12/2018 - 10/2012
2Oxycodone (Oxycontin)FDA LinkGeneric
01/2022 - 11/2017
2Morphine (MS Contin)FDA LinkGeneric
10/2021 - 12/2018
2Modafinil (Provigil)FDA Link
08/2017 - 06/2015
2Cocaine (Cocaine HCl)IBA
01/2017 - 10/2012
1GhrelinIBA
01/2022
1N- (4- (4- (2,3- dichlorophenyl)piperazin- 1- yl)but- 2- enyl)- 4- pyridine- 2- ylbenzamideIBA
10/2021
1Glutamic Acid (Glutamate)FDA Link
01/2021
1Xie2-64IBA
10/2020
1XLR-11IBA
01/2020
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
01/2020
1Dronabinol (THC)FDA LinkGeneric
01/2020
1NicotineFDA Link
12/2019
1R-VK4-40IBA
11/2019
1AM4113IBA
03/2019
1RimonabantIBA
03/2019
1VK4-116IBA
01/2019
1Heroin (Diamorphine)IBA
12/2018
1Naloxone (Narcan)FDA LinkGeneric
12/2018
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
12/2018
1metabotropic glutamate receptor 2IBA
12/2018
1LigandsIBA
11/2017
1BAK4-54IBA
11/2017
1CAB2-015IBA
11/2017
1N- (2- ((bis(4- fluorophenyl)methyl)thio)ethyl)- 3- phenylpropan- 1- amineIBA
08/2017
1Opiate AlkaloidsIBA
01/2017
1Biomarkers (Surrogate Marker)IBA
10/2016
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
03/2015
1YQA14IBA
02/2014
1fenobamIBA
09/2013
1Sulfates (Sulfates, Inorganic)IBA
09/2013

Therapy/Procedure

4Self Administration (Administration, Self)
12/2019 - 11/2017
3Analgesia
01/2021 - 12/2018
2Therapeutics
11/2019 - 01/2017
1Drug Therapy (Chemotherapy)
01/2019